| Followers | 843 |
| Posts | 123038 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Wednesday, January 18, 2023 9:09:12 AM
ABBV introduces Juvederm Volux—a_dermal_filler_for jawline augmentation:
https://finance.yahoo.com/news/juv-derm-volux-xc-improvement-130000644.html
This offering expands the Juvederm XC product line, which includes, in ascending order of heaviness: Volbella (for lips); Vollure (for nasolabial folds); Voluma (for mid-face augmentation), and Volux (for jawline).
https://finance.yahoo.com/news/juv-derm-volux-xc-improvement-130000644.html
This offering expands the Juvederm XC product line, which includes, in ascending order of heaviness: Volbella (for lips); Vollure (for nasolabial folds); Voluma (for mid-face augmentation), and Volux (for jawline).
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ABBV News
- AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia • PR Newswire (US) • 05/29/2026 12:00:00 PM
- U.S. FDA Approves DECNUPAZTM (pivekimab sunirine-pvzy) for Treatment of Adult Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare and Aggressive Blood Cancer With Limited Treatment Options • PR Newswire (US) • 05/27/2026 10:18:00 PM
- AbbVie Announces Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection • PR Newswire (US) • 05/22/2026 12:00:00 PM
- AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline • PR Newswire (US) • 05/21/2026 10:46:00 PM
- Allergan Aesthetics Receives Positive CHMP Opinion for Boey® (TrenibotulinumtoxinE) for the Temporary Improvement of Moderate to Severe Glabellar Lines in Adults • PR Newswire (US) • 05/21/2026 08:10:00 PM
- CNS Drug Delivery Technologies Are Reshaping Alzheimer's and Biodefense Research • InvestorsHub NewsWire • 05/13/2026 01:00:00 PM
- Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities • InvestorsHub NewsWire • 05/13/2026 01:00:00 PM
- Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities • GlobeNewswire Inc. • 05/13/2026 12:30:00 PM
- CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research • GlobeNewswire Inc. • 05/13/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 09:01:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/12/2026 09:00:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/12/2026 09:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/12/2026 09:00:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2026 04:28:48 PM
- AbbVie to Present at the Bank of America Securities Healthcare Conference • PR Newswire (US) • 05/06/2026 12:00:00 PM
- AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week® • PR Newswire (US) • 05/05/2026 12:05:00 PM
- SKYRIZI® (risankizumab) Secures Listing on Ontario and Alberta Formularies in Ulcerative Colitis • PR Newswire (Canada) • 05/04/2026 11:01:00 AM
- SKYRIZI® (risankizumab) est inscrit aux listes des médicaments remboursés de l'Ontario et de l'Alberta pour le traitement de la colite ulcéreuse • PR Newswire (Canada) • 05/04/2026 11:01:00 AM
- AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec • GlobeNewswire Inc. • 04/30/2026 07:00:00 PM
- Allergan Aesthetics Launches Philanthropic Effort in Recognition of Skin Cancer Awareness Month • PR Newswire (US) • 04/30/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:50:28 AM
- AbbVie Reports First-Quarter 2026 Financial Results • PR Newswire (US) • 04/29/2026 11:47:00 AM
- Markets Steady Ahead of Fed Decision and Key Tech Earnings: Dow Jones, S&P, Nasdaq, Wall Street Futures • IH Market News • 04/29/2026 09:16:13 AM
- Markets Hold Steady Ahead of Fed Call and Big Tech Earnings: Dow Jones, S&P, Nasdaq, Wall Street Futures • UK Market News • 04/29/2026 09:15:43 AM
- AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata • PR Newswire (US) • 04/28/2026 12:00:00 PM
